Buning Tian

428 total citations
16 papers, 279 citations indexed

About

Buning Tian is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Buning Tian has authored 16 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Buning Tian's work include Circular RNAs in diseases (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Cancer-related molecular mechanisms research (4 papers). Buning Tian is often cited by papers focused on Circular RNAs in diseases (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Cancer-related molecular mechanisms research (4 papers). Buning Tian collaborates with scholars based in China. Buning Tian's co-authors include Xiaorong Li, Yihang Guo, Changwei Lin, Jianyu Zhou, Meirong Wu, Hao Li, Daojin Chen, Gang Liu, Gui Hu and Fei Long and has published in prestigious journals such as Molecular Cancer, Cancers and Journal of Gastrointestinal Surgery.

In The Last Decade

Buning Tian

16 papers receiving 275 citations

Peers

Buning Tian
Hongda Pan China
Annalisa Comandatore Italy
Sina Zhang China
Christina Schleicher Germany
Chongguo Zhang China
Jaroslav Juráček Czechia
Haofeng Lu China
Yiran Zou China
Junge Deng China
Fuxi Zhen China
Hongda Pan China
Buning Tian
Citations per year, relative to Buning Tian Buning Tian (= 1×) peers Hongda Pan

Countries citing papers authored by Buning Tian

Since Specialization
Citations

This map shows the geographic impact of Buning Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buning Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buning Tian more than expected).

Fields of papers citing papers by Buning Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buning Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buning Tian. The network helps show where Buning Tian may publish in the future.

Co-authorship network of co-authors of Buning Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Buning Tian. A scholar is included among the top collaborators of Buning Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buning Tian. Buning Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Tian, Buning, Liang Li, Zhijian J. Chen, et al.. (2023). CircPOFUT1 fosters colorectal cancer metastasis and chemoresistance via decoying miR-653-5p/E2F7/WDR66 axis and stabilizing BMI1. iScience. 27(1). 108729–108729. 5 indexed citations
3.
Lin, Changwei, Min Ma, Yi Zhang, et al.. (2022). The N6-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p/PGF signalling pathway. Molecular Cancer. 21(1). 80–80. 54 indexed citations
4.
5.
Luo, Jia, Kai Gao, Miao Chen, & Buning Tian. (2022). LINC01210 promotes malignant phenotypes of colorectal cancer through epigenetically upregulating SRSF3. Pathology - Research and Practice. 234. 153905–153905. 2 indexed citations
6.
Wu, Junhui, Xiaocheng Tang, Min Ma, et al.. (2020). Identification of circular RNA hsa_circ_0044556 and its effect on the progression of colorectal cancer. Cancer Cell International. 20(1). 427–427. 16 indexed citations
7.
Zhou, Jianyu, Xiaorong Li, Meirong Wu, et al.. (2016). Knockdown of Long Noncoding RNA GHET1 Inhibits Cell Proliferation and Invasion of Colorectal Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 23(6). 303–309. 69 indexed citations
8.
Zhou, Jianyu, Changwei Lin, Gui Hu, et al.. (2015). Combinational treatment with microRNA-133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR. Molecular Medicine Reports. 12(4). 5407–5414. 27 indexed citations
9.
Yang, Man, et al.. (2015). Prognostic validation of the WHO 2010 grading system in pancreatic insulinoma patients. Neoplasma. 62(3). 484–490. 3 indexed citations
10.
Li, Hao, et al.. (2014). Factors Predicting Surgical Resection in Patients with Intrahepatic Cholangiocarcinoma and Cirrhosis. Journal of Investigative Surgery. 27(4). 219–225. 8 indexed citations
11.
Li, Hao, Xintian Wang, Gang Liu, et al.. (2013). Major Hepatectomy Is a Safe Modality for the Treatment of Intrahepatic Cholangiocarcinoma in Selected Patients Complicated with Cirrhosis. Journal of Gastrointestinal Surgery. 18(1). 194–199. 6 indexed citations
12.
Gao, Kai, et al.. (2012). Expression of deleted in liver cancer 2 in colorectal cancer and its correlation with clinicopathological parameters. Oncology Letters. 4(5). 988–992. 3 indexed citations
13.
Chen, Daojin, Xiaorong Li, Buning Tian, et al.. (2011). Clinicopathological Characteristics of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis. Hepatogastroenterology. 58(110-111). 1787–90. 3 indexed citations
14.
Li, Hao, et al.. (2011). Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment. Journal of Gastrointestinal Surgery. 15(4). 608–613. 55 indexed citations
15.
Yang-de, Zhang, et al.. (2007). [Expression of X-linked inhibitor of apoptosis protein in colorectal cancer tissues].. PubMed. 27(11). 1746–8. 1 indexed citations
16.
Yang-de, Zhang, et al.. (2007). [Sentinel lymph node mapping in colorectal cancer: study of 45 cases].. PubMed. 87(44). 3125–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongda Pan Breakdown of academic impact, for papers by Annalisa Comandatore Breakdown of academic impact, for papers by Sina Zhang Breakdown of academic impact, for papers by Christina Schleicher Breakdown of academic impact, for papers by Chongguo Zhang Breakdown of academic impact, for papers by Jaroslav Juráček Breakdown of academic impact, for papers by Haofeng Lu Breakdown of academic impact, for papers by Yiran Zou Breakdown of academic impact, for papers by Junge Deng Breakdown of academic impact, for papers by Fuxi Zhen
Rankless by CCL
2026